In Maryland June 25th, the U.S. Food and Drug Administration approved Epidiolex (cannabidiol) CBD oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. Two rare and severe forms of epilepsy. This is the first FDA approved drug containing cannabidiol (CBD) a derivative of marijuana. Epidiolex is an oral solution for patients two […]